"Lifetime use of MDMA, which also mainly affects men (11.7% compared to 4.9% of women), rose sharply between 2017 and 2023 (increasing from 5.0% to 8.2%), and its current use has doubled (from 1.0% to 1.8%), 25–34-year-olds being the most likely to have tried it (13.8%). This increase was proportionally greater for women (0.6% to 1.3%) than men (1.5% to 2.4%)."
Source
l'Observatoire francais des drogues et des toxicomanies (OFDT). 2024 National report (2023 data) to the EUDA by the French Reitox National Focal Point. Workbook 3: Drugs. Dec. 1, 2024.
